纤维性结构不良/麦库恩-奥尔布赖特综合征的发病率和患病率:丹麦全国性登记研究
基于丹麦全国患者登记1995-2018年的队列研究,识别408例纤维性结构不良/麦库恩-奥尔布赖特综合征(FD/MAS)患者,其中单骨型FD 269例(66%)、多骨型FD/MAS 139例(34%)。FD/MAS发病率呈上升趋势,2015-2018年为3.6/100万人年(95%CI:2.9,4.5),发病高峰在11-20岁,2018年患病率为61.0/100万人(95%CI:54.6,67.4)。未登记到FD/MAS相关低磷血症的诊断或治疗病例。
要点
- FD/MAS罕见,发病高峰在青春期(11-20岁),无性别差异,单骨型FD最多见。
- 2015-2018年FD/MAS发病率为3.6/100万人年(95%CI:2.9,4.5),呈上升趋势。
- 2018年FD/MAS患病率为61.0/100万人(95%CI:54.6,67.4),随时间增加。
核心结论
- FD/MAS罕见,诊断高峰在青春期,无性别优势,单骨型FD最流行。
- 低磷血症可能被漏诊和治疗不足,或相较于文献被低登记。
研究设计与样本
- 基于丹麦全国患者登记1995-2018年的队列研究,通过ICD-10编码M85.0(单骨型FD)和Q78.1(多骨型FD/MAS)识别患者。
- 共识别408例患者,其中单骨型FD 269例(66%),多骨型FD/MAS 139例(34%),两性可比。
主要发现
- FD/MAS发病率呈上升趋势,2015-2018年为3.6/100万人年(95%CI:2.9,4.5)。
- 发病高峰在11-20岁。
- FD/MAS患病率随时间增加,2018年为61.0/100万人(95%CI:54.6,67.4)。
- 单骨型FD发病率在第一个十年为多骨型FD/MAS的1.5倍,在最后一个十年升至2.5倍。
- 未登记到FD/MAS病例有低磷血症的诊断编码或治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare genetic disorder. Incidence and prevalence are not well-studied. Epidemiological research is complicated by the rarity of FD/MAS, absence of registries, heterogeneous presentation, and possibly asymptomatic phenotype. FD/MAS may present with FGF23-mediated hypophosphatemia, of which the epidemiology is also unclear. OBJECTIVE: Evaluate incidence and prevalence of FD/MAS and FD/MAS-related hypophosphatemia. METHODS: This cohort study based on the nationwide Danish National Patient Registry from 1995-2018, included patients identified by ICD-10 codes M85.0 (monostotic FD [MFD]) and Q78.1 (polyostotic FD [PFD]/MAS). Incidence rates and prevalence were calculated and stratified by sex, age, calendar period, and diagnosis code. Cases were screened for FD-associated hypophosphatemia by diagnosis code E.83 (disorder of mineral metabolism) and dispatched vitamin D analogues. RESULTS: A total of 408 patients were identified, 269 with MFD (66%), 139 with PFD/MAS (34%), comparable between sexes. Incidence of FD/MAS demonstrated increasing secular trend with a rate of 3.6 per 1 000 000 person-years (95% CI: 2.9, 4.5) in 2015-2018. Incidence peaked between age 11 and 20. Prevalence of FD/MAS increased over time to 61.0 (95% CI: 54.6, 67.4) per 1 000 000 persons in 2018. The incidence rate of MFD was 1.5-fold that of PFD/MAS in the first decade, rising to 2.5-fold in the last decade. No FD/MAS cases were registered with diagnosis code or treatment for hypophosphatemia. CONCLUSION: FD/MAS is rare, diagnosis peaks during adolescence without sex predominance, and MFD is most prevalent. Hypophosphatemia may be underdiagnosed and undertreated, or it may be underregistered, comparing this study to literature.
引用
- Meier ME, Vágó E, Abrahamsen B, et al. Incidence and Prevalence of Fibrous Dysplasia/McCune-Albright Syndrome: A Nationwide Registry-Based Study in Denmark. J Clin Endocrinol Metab. 2024. PMID: 38174586. doi:10.1210/clinem/dgad744
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。